313 related articles for article (PubMed ID: 28089147)
1. SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry.
Assadi-Schmidt A; Mohring A; Liebsch E; Dannenberg L; Achilles A; Pöhl M; Afzal S; Veulemans V; Horn P; Sansone R; Bönner F; Levkau B; Kelm M; Zeus T; Polzin A
Int J Cardiol; 2017 Mar; 231():68-72. PubMed ID: 28089147
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
[TBL] [Abstract][Full Text] [Related]
3. Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis: Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study.
Galli S; Troiano S; Tespili M; Ielasi A; Niccoli G; Sommariva L; Amico F; Pasquetto G; Ceravolo R; Forlani D; Contarini M; Del Maestro M; Montorsi P
J Cardiovasc Med (Hagerstown); 2021 Jun; 22(6):469-477. PubMed ID: 33896930
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
[TBL] [Abstract][Full Text] [Related]
6. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
7. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
[TBL] [Abstract][Full Text] [Related]
8. Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
Venetsanos D; Omerovic E; Sarno G; Pagonis C; Witt N; Calais F; Böhm F; Jurga J; Völz S; Koul S; Olivercrona G; James S; Alfredsson J
Int J Cardiol; 2021 Feb; 325():30-36. PubMed ID: 32980433
[TBL] [Abstract][Full Text] [Related]
9. Major adverse cardiac events and drug-coated balloon size in coronary interventions.
Naguib D; Knoop B; Dannenberg L; Liebsch E; Pöhl M; Helten C; Assadi-Schmidt A; Kelm M; Zeus T; Polzin A
Anatol J Cardiol; 2018 Jun; 19(6):382-387. PubMed ID: 29848922
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
Hu P; Sun Y; Li CL; Jin R; Xie Q; Jiang XJ; Wu LP; Jiang JJ; Qiu XB; Cao Y; Ji G; Wang H; Yao ZH; Li B; Xia Y; Wang JA; Jiang J
Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():988-995. PubMed ID: 33734575
[TBL] [Abstract][Full Text] [Related]
11. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of a novel iopromide-based paclitaxel-coated balloon Shenqi versus SeQuent Please for the treatment of in-stent restenosis.
Zhu J; Liu L; Zhu Z; Yang Z; Hu J; Ding F; Zhou Y; Su X; Ge J; Liu X; Tang L; He Y; Zhou G; Ji Z; Li Y; Pang W; Zhang R
Coron Artery Dis; 2021 Sep; 32(6):526-533. PubMed ID: 33229940
[TBL] [Abstract][Full Text] [Related]
13. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis.
Liu S; Zhou Y; Shen Z; Chen H; Qiu C; Fu G; Li H; Yu Z; Zeng Q; Li Z; Li W; Qiao S;
JACC Cardiovasc Interv; 2023 Apr; 16(7):759-767. PubMed ID: 37045496
[TBL] [Abstract][Full Text] [Related]
15. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
[TBL] [Abstract][Full Text] [Related]
17. Differences in clinical outcomes between pre- and post-marketing clinical study following paclitaxel-coated balloon catheter treatment for coronary in-stent restenosis: from the Japanese regulatory viewpoint.
Mitsutake Y; Konishi A; Shiba T; Ito T; Ho M; Shirato H
Heart Vessels; 2021 Feb; 36(2):155-162. PubMed ID: 32776235
[TBL] [Abstract][Full Text] [Related]
18. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
[TBL] [Abstract][Full Text] [Related]
19. Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry.
Resch M; Ostheim P; Endemann DH; Debl K; Buchner S; Birner C; Maier LS; Kerber S; Luchner A; Griese DP
J Interv Cardiol; 2016 Oct; 29(5):461-468. PubMed ID: 27477024
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
